Vanadium inhibits placental glutathione S-transferase (GST-P) positive foci in 1,2-dimethyl hydrazine induced rat colon carcinogenesis

Journal of Biochemical and Molecular Toxicology

Volumn 17, Issue 6, 2003, Pages 357-365

  Kanna, P Suresh ^a   Mahendrakumar, C B ^a   Chatterjee, M ^a   Hemalatha, P ^a   Datta, Subroto ^a   Chakraborty, Prabir ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

1,2 dimethyl hydrazine (1,2 DMH); Aberrant crypt foci (ACF); Glutathione S transferase (GST P); Super oxide dismutase (SOD); Vanadium

Indexed keywords

CARCINOGEN; GLUTATHIONE TRANSFERASE; HYDRAZINE DERIVATIVE; LIVER ENZYME; PLACENTA ENZYME; SUPEROXIDE DISMUTASE; VANADIUM; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL CARCINOGENESIS; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MALE; NONHUMAN; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CARCINOGENS; COLONIC NEOPLASMS; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; LIVER; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; VANADIUM;

ANIMALIA;

EID: 0347917181     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10099     Document Type: Article

References (42)

1. Greenle RT, Murray T, Bolden S, Wingo PA. Cancer Statistics CA. Cancer J Clin 2000;50:7-33.
2. Pitot HC. Fundamentals of Oncology. New York: Marcel Dekker; 1986.
3. Pozharisski KM, Likhachev AJ, Klimashevski VF, Shaposhnikov JD. Experimental intestinal cancer research with special reference to human pathology. Adv Cancer Res 1979;30:165-237.
4. Druckrey E. Organ-specific carcinogenesis in the digestive tract. In: Nakahara W, Takayama S, Sugimura T, Odashima S, editors. Topics in Chemical Carcinogenesis. Baltimore, MD: University Park; 1972. pp. 73-101.
5. Wattenberg LW. An overview of chemoprevention: Current status and future prospects. Proc Soc Exp Bio Med 1997;216:133-141.
6. Osborne M, Boyle P, Lipkin M. Cancer prevention. Lancet 1997;349(Suppl II):27-30.
7. Crans DC, Bunch RJ, Theisen LA. Interaction of trace levels of vanadium (IV) and vanadium (V) in biological system. J Am Chem Soc 1989;111:7597-7607.
8. Bishayee A, Chatterjee M. Time course effects of vanadium supplement on cytosolic reduced glutathione level and glutathione S-transferase activity. Biol Trace Element Res 1995;48:275-285.
9. Simons TJB. Vanadate: A new tool for biologists. Nature 1979;281:337-338.
10. Macara IG. Vanadium: An element in search of a role. Trends Biochem Sci 1980;2:92-94.
11. Shi X, Dalal NS. One electron reduction of vanadium (V) by flavoenzymes NADPH. Arch Biochem Biophys 1993;302:300-305.
12. Kopf-Maier P. Cytostatic nonplatinum metal complexes: New perspective for the treatment of cancer? Naturwissenschaften 1987;74:374-382.
13. Bishayee A, Chatterjee M. Selective enhancement of glutathione S-transferase activity in liver and extra hepatic tissues of rat following oral administration of vanadate. Acta Physiol Pharmacol Bulg 1993;19:83-89.
14. Thompson HJ, Chasteen ND, Meeker LD. Dietary vanadyl (IV) sulfate inhibits chemically induced mammary carcinogenesis. Carcinogenesis 1984;5:849-851.
15. Sardar S, Chatterjee M. Vanadium: A possible role in the protection of host cells bearing transplantable murine lymphoma. Tumour Res 1993;18:51-61.
16. Bishayee A, Chatterjee. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by Phenobarbital. British J Cancer 1995;71:1214-1220.
17. Kanna PS, Mahendrakumar CB, Tridib Chakraborty, Hemalatha P, Pratik Banerjee. Effect of vanadium on aberrant crypt foci induced in 1,2 dimethyl hydrazine. World J Gastroenterol 2003;9(5):1020-1027.
18. Bishayee A, Rosy S, Chatterjee M. Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncol Res 1999;11:41-53.
19. Kantor RR, Giardina SL, Bartolazzi A, Townsend AJ, Myers CE, Cowan KH, Longo DL, Natali PG. Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer 1991;47:193-201.
20. Iowie AF, Forrester LM, Glancey MJ, Schlager JJ, Powis G, Beck-ett GJ, Hayes JD, Wolf CR. Glutathione S-transferase and glutathione peroxidase expression in normal and tumor human tissues. Carcinogenesis 1990;11:451-458.
21. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
22. Morse MA, Stoner GD. Cancer chemoprevention: Principles and prospects. Carcinogenesis 1993;14:1737-1746.
23. Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, Takimoto R, Kogawa K, Kato J, Sakamaki S, Niitsu Y. Glutathione S-transferase-pi over expression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterol 2001;121(4):865-874.
24. Peters WH, Roelofs HM. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J 1989;264(2):613-616.
25. Ranganathan S, Tew KD. Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon. Carcinogenesis 1991;12(12):2383-2387.
26. Kodate C, Fukushi A, Narita T, Kudo H, Soma Y, Sato K. Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. Japan J Cancer Res 1986;77(3):226-229.
27. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995;93:55-71.
28. Kaku T, Ekem J, Lindayen C, Bailey D, van Nostrand A, Farber E. Comparison of formalin and acetone fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin. Am J Clinical Pathol 1983;80:806-815.
29. Bondi A, Chieregatti G, Eusebi U, Fulcheri E, Bussolati G. The use of B galactosidase stain as a tracer in immunohistochemistry. Histochemistry 1982:76:153-158.
30. Beyer WF Jr, Fridovich I. Assaying for superoxide dismutase activity: Some large consequence of minor changes in conditions. Anal Biochem 1987;161:559-566.
31. 3 inhibit diethylnitrosamine-induced rat liver carcinogenssis. Chemico-Biol Inter 2000;128:1-18.
32. 3 inhibits placental glutathione S-transferase positive foci in rat liver carcinogenesis. Life Sci 2000;68:217-231.
33. Chatterjee M, Bishayee A. Vanadium: A new tool for cancer prevention. In: Vanadium in Environment, Part 2, New York: Wiley; 1998.
34. McLellan EA, Medline A, Bird RP. Dose response and proliferate characteristics of aberrant crypt foci: Putative preneoplastic lesions in rat colon. Carcinogenesis 1991;12:2093-2098.
35. Pereira MA, Barnes LH, Rassman VL, Kolloff GV, Steele VE. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 1994;15:1049-1054.
36. Tanaka T, Mori H. Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J Toxicol Pathol 1996;9:139-149.
37. Goldstein BD, Czerniecki B, Witz G. The role of free radicals in tumor promotion. Environ Health Perspec 1989;81:55-57.
38. Trush MA, Kensler TW. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radical Biol Med 1991;10:201-209.
39. Pence CB. Dietary selenium and antioxidant status: toxic effects of 1,2-dimethyl hydrazine in rats. J Nut 1991;121:138-144.
40. Herzfeld A, Greengar O. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 1977;37:231-238.
41. Oberley LW, Bettner GR. Role of Superoxide Dismutase in cancer: A review. Cancer Research 1979;39:1141-1149.
42. Byne AR, Kosta L. Vanadium in foods and in human body fluids and tissues. Sci Total Envrion 1978;10:17-30.